Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of...
Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: A phase 2 randomized, double-blind study
About this item
Full title
Author / Creator
Publisher
Netherlands: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Highlights•TAK-214 norovirus vaccine is well tolerated in children from 1 to 8 years of age. •Immune responses were similar in two cohorts of 1–3 and 4–8 year-olds. •Reactogenicity and immunogenicity were not affected by increasing dosage of TAK-214. •Responses were not markedly increased by a second dose in these populations. •Despite waning antib...
Alternative Titles
Full title
Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: A phase 2 randomized, double-blind study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2675577835
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2675577835
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2022.04.089
